NEW YORK STATE COMMON RETIREMENT FUND - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 77 filers reported holding ONCOCYTE CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2022$1,000
-98.1%
573
-98.4%
0.00%
Q1 2022$54,000
-30.8%
36,0730.0%0.00%
Q4 2021$78,000
-39.5%
36,073
-0.4%
0.00%
Q3 2021$129,000
-53.8%
36,212
-25.6%
0.00%
Q2 2021$279,000
+11.6%
48,693
+1.2%
0.00%
Q1 2021$250,000
+166.0%
48,100
+22.1%
0.00%
Q4 2020$94,000
+70.9%
39,4000.0%0.00%
Q3 2020$55,000
-26.7%
39,4000.0%0.00%
Q2 2020$75,000
+200.0%
39,400
+294.0%
0.00%
Q1 2020$25,000
+8.7%
10,0000.0%0.00%
Q4 2019$23,000
+9.5%
10,0000.0%0.00%
Q3 2019$21,000
-79.0%
10,000
-75.0%
0.00%
Q2 2019$100,000
+203.0%
40,000
+154.8%
0.00%
Q1 2018$33,000
-54.8%
15,7000.0%0.00%
Q4 2017$73,000
-38.7%
15,7000.0%0.00%
Q3 2017$119,000
+45.1%
15,7000.0%0.00%
Q2 2017$82,000
+30.2%
15,700
+15.7%
0.00%
Q1 2016$63,00013,5740.00%
Other shareholders
ONCOCYTE CORP shareholders Q2 2022
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 23,353,697$17,048,0001.30%
AWM Investment Company, Inc. 7,746,557$5,655,0000.86%
PURA VIDA INVESTMENTS, LLC 18,056,274$13,181,0000.76%
Defender Capital, LLC. 2,551,980$1,883,0000.74%
Penbrook Management LLC 563,350$411,0000.35%
ACT CAPITAL MANAGEMENT, LLC 330,000$241,0000.33%
CALIBER WEALTH MANAGEMENT, LLC 75,120$55,0000.04%
Fort Sheridan Advisors LLC 135,000$99,0000.03%
Orbimed Advisors 1,882,768$1,374,0000.03%
WEALTH EFFECTS LLC 51,000$37,0000.02%
View complete list of ONCOCYTE CORP shareholders